Medical Oncologists play a central role in the diagnosis, treatment, and management of cancer. These highly trained physicians specialize in the use of chemotherapy, immunotherapy, hormone therapy, and targeted therapies to treat cancer in its various forms. After a diagnosis is confirmed—often through biopsies or imaging—a medical oncologist works closely with a multidisciplinary team, including radiation oncologists, surgical oncologists, pathologists, and radiologists, to develop a personalized treatment plan for each patient. Their goal is not only to treat the disease but also to manage symptoms and improve quality of life throughout the cancer journey. They also serve as key coordinators, ensuring that all aspects of care are seamlessly integrated across specialties. This coordination helps minimize delays and enhances patient outcomes.
Beyond administering systemic therapies, medical oncologists monitor treatment responses, adjust medication regimens, and provide critical support for managing side effects. Medical oncologists also play a key role in survivorship care, helping patients transition to life after treatment while addressing long-term health concerns. Their comprehensive approach and compassionate care make them essential figures in a patient’s fight against cancer, offering both medical expertise and emotional support during one of life’s most challenging experiences. Through ongoing education and research, they remain at the leading edge of advancements in oncology.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China